Exagen (XGN) Cash from Investing Activities (2018 - 2026)
Exagen's (XGN) quarterly Cash from Investing Activities came in at -$228000.0 in Q1 2026, down 113.08% YoY from $1.7 million in Q1 2025, and down 551.43% on a QoQ basis from -$35000.0 in Q4 2025.
Exagen (XGN) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Exagen (XGN) has 9 years of Cash from Investing Activities data on file, last reported at -$228000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 113.08% year-over-year to -$228000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$747000.0 (down 39.37% YoY) and the FY2025 annual result came in at -$626000.0, down 21.55% from the prior year.
- Cash from Investing Activities eased to -$228000.0 in Q1 2026, from -$35000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$2000.0 in Q3 2023 to a low of -$1.9 million in Q2 2022.
- A 5-year average of -$381823.5 and a median of -$209000.0 in 2025 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 99.77% — and 2024, when it slumped 7250.0%.
- Tracing XGN's Cash from Investing Activities over 5 years: stood at -$406000.0 in 2022, then soared by 79.31% to -$84000.0 in 2023, then sank by 73.81% to -$146000.0 in 2024, then jumped by 76.03% to -$35000.0 in 2025, then tumbled by 551.43% to -$228000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$228000.0 (Q1 2026), -$35000.0 (Q4 2025), and -$275000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -25.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -366.20 Mn |
| 10 | Exagen | 181.48 Mn | 156.88 Mn | 12.22 Mn | -543,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -543,000.00 |
| Jun 30, 2026 | -543,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Mar 31, 2025 | -107,000.00 |
| Dec 31, 2024 | -146,000.00 |
| Dec 31, 2024 | -146,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Sep 30, 2024 | -147,000.00 |
| Jun 30, 2024 | -136,000.00 |
| Jun 30, 2024 | -136,000.00 |
| Mar 31, 2024 | -86,000.00 |
| Mar 31, 2024 | -86,000.00 |